Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glucometabolic Evaluation of Idiopathic Ketotic Hypoglycemia
NCT05310292Unknown
- Sponsor
- Gentofte Hospital
- Start
- Mar 2022
- Primary completion
- Apr 2024
- Countries
- 1
01
Overview
Open-label trial in idiopathic ketotic hypoglycemia (IKH), sponsored by Gentofte Hospital. Primary endpoints: Plasma glucose at 180 months and Time in range (CGM) at 14 days. Status: unknown.
02
Conditions
idiopathic ketotic hypoglycemia (IKH)
Beyond the preview
Go deeper on NCT05310292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05310292.